Perspectives

Sharing the Mission to Conquer Rare Diseases

SHARING THE MISSION TO CONQUER RARE DISEASES

At a rapid pace, biopharmaceutical companies and patient advocacy groups are banding together to hasten development of new drugs for rare diseases. These relationships are bringing new value to both sides but raising challenges as well – patient groups are seeking earlier engagement, greater access, and companies continue to push for progress.

The latest report from inVentiv Health Public Relations Group – based on several months of extensive research and in-depth interviews - takes a deeper look at the dynamics currently reshaping collaboration in rare disease and how future roles will be defined.